← The Crash Report
The Gap

Hyundai Sells a Car 142 Times Deadlier Than Its Safest Model. The Badge Didn’t Warn You.

Split showroom floor: a safe family SUV under warm light and a fragile sports car under red warning light, same brand badge

Hyundai’s Palisade kills 0.06 people per 100 million vehicle miles traveled. Walk across the showroom floor, past the financing desk and the complimentary coffee, and sit in a Veloster. Same badge. A fatality rate of 8.54.[1]

142×
Fatality rate gap between Hyundai’s safest and deadliest models, 2014–2023

Same logo on the steering wheel, same dealership, same brand promise, and a 142-fold difference in how often someone dies.

Hyundai isn’t uniquely reckless — they’re just the most dramatic example. Ford spans 120× between the Bronco (0.05) and the Mustang (6.02). Chevrolet manages 41× between the C/K Pickup and the Tracker, a rebadged Suzuki whose 856 deaths came on a 12.7% impairment rate, meaning seven out of every eight fatal-crash drivers blew clean.[1] Toyota, the brand that built its reputation on reliability-as-safety, spans 33× from the RAV4 to the Land Cruiser, whose drivers tested impaired just 8.9% of the time while dying at 6.27 per 100M VMT.[2]

Impairment data demolishes the easy excuse. You could argue that Velosters attract reckless young men who wrap themselves around telephone poles on Saturday nights, and you wouldn’t be entirely wrong. But its impairment rate is 17.4%, which is lower than the “safe” RAV4 at 18.4%. A Veloster kills sober drivers because 2,600 pounds of subcompact platform doesn’t have the crush space to manage crash energy progressively; the occupant compartment intrudes instead.[1][3]

Mass explains most of this. IIHS research found that every additional 500 pounds below the 4,000-pound fleet average reduces driver death rates by 17 per million registered vehicle years.[3] At 4,500 pounds the Palisade sits above that threshold; at 2,600 the Veloster sat far below it. Hyundai wasn’t operating under a single crashworthiness philosophy so much as letting physics sort survivors from the dead across eleven models and a $31,000 price spread.

A caveat on the extremes: the Palisade’s 0.06 rate rests on 38 deaths and the Bronco’s 0.05 on 25, so the precise multiplier carries real statistical noise at the tails. Rates use NHTS average annual VMT by vehicle class rather than odometer readings, adding roughly ±15% uncertainty for low-volume models.[2] Double the Palisade’s rate, halve the Veloster’s, and you still get a 35× gap within a single showroom.

Self-selection deserves its full weight as a counterargument. Veloster buyers probably drive faster and less cautiously than Palisade families, and impairment data captures substances but not speed, distraction, or risk appetite. Some of that 142× is the car, some the driver it attracts, and no published study has separated the two.

But the actionable point doesn’t require untangling car from driver. If you’re shopping Hyundai because you “trust the brand,” the brand is selling you vehicles spanning functionally zero risk to eight times the national fatal crash average. A Palisade, Santa Fe, Tucson, or Kona will carry you at rates between 0.06 and 0.34. An Elantra or Sonata will triple to quintuple that. Look up your model at iihs.org/ratings and check your VIN at nhtsa.gov/recalls, because the badge won’t do that homework for you.

Every showroom floor is a roulette wheel. Pick the right model and the wheel barely spins.

Sources & References

  1. NHTSA, Fatality Analysis Reporting System (FARS), 2014–2023. Cross-tabulation of deaths, estimated fleet VMT, and impairment toxicology by make and model. nhtsa.gov
  2. NHTS, National Household Travel Survey. Annual VMT estimates by vehicle type used for rate denominators. nhts.ornl.gov
  3. Monfort, S. et al., “Crash incompatibility between cars, SUVs, and pickups in 2017–2022,” Traffic Injury Prevention, 2024. IIHS. iihs.org

Source: NHTSA FARS 2014–2023. Fatality rates are estimated using modeled fleet VMT from NHTS averages, not actual odometer data, introducing ±15% uncertainty for low-volume models. Impairment is BAC>0 or drug-positive toxicology in fatal crashes only and does not capture speed, distraction, or non-substance risk factors. See methodology for caveats.